Arjo (ARJO-B.ST) Stock Analysis & AI Equity Report
Arjo (ARJO-B.ST) overview
Arjo (ARJO-B.ST) stock analysis and AI equity research. For the latest completed financial year, 2024, Arjo reported revenue of SEK 11,292m and operating profit of SEK 893m; the year-end share price was 36.26 SEK and market capitalisation was SEK 9,876m. Arjo is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Arjo's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-18. Data will be refreshed during report generation.
About Arjo
Arjo AB develops and supplies medical devices and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, and venous thromboembolism prevention. It also provides related services and training. The company sells to healthcare providers globally and focuses on helping caregivers improve mobility, safety, infection control, and care efficiency.
Generate the Arjo report
Arjo is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Arjo and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.